Elevance Health Raises 2026 Earnings Guidance Following Strong Q3 Performance
Elevance Health (ELV) has raised its adjusted earnings per share (EPS) guidance for 2026 to at least $29. This upward revision follows a strong third quarter where the company outperformed expectations across several key segments, including Medicaid, Medicare Advantage, and Individual ACA plans. Looking further ahead, management has set an ambitious target of achieving at least 12% growth in 2027. CEO Gail Boudreaux attributed the positive momentum to robust performance across its diverse insurance portfolios, signaling long-term confidence in the company's operational trajectory.
Tickers: $ELV
Topics: ACA earnings report guidance increase Medicaid Medicare Advantage
Read the full article at Seeking Alpha
Part of the story Equinix Reports Strong Q3 2026 Results and Raises Full-Year Guidance (49 articles)